Todd C. Davis, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 10,166 shares at $213.14 ($2.2M) on 2021-02-10, disclosed to the SEC on 2021-02-12.
Open-market sale of $2.2M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $213.14 | 5,083 | $1.1M | 50.0% |
| 2 | $213.14 | 5,083 | $1.1M | 50.0% |
| Total | $213.14 avg | 10,166 | $2.2M | 100% |
| Filing → |
| LGND | BUY | 2024-08-09 | $243K | — | Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| BDSI | SELL | 2020-08-20 | $250K | — | Filing → |